Eli Lilly
$LLY (+1,93 %)-CEO David Ricks stated that the company expects its experimental weight loss pill will be approved early next year, reports Bloomberg.
The drug could be a major breakthrough in the growing market for weight-control therapies.
Graphic: Bloomberg
